Learn Before
Concept
Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study
- This study attempts to analyze how COVID-19 illness affects those with lymphoma based on data gathered on 89 patients with these comorbidities in a database of 12 hospitals located in 3 French regions
- Out of the 89 patients, the mean age was 67 years old and 66% were male
- 72 of the 89 has other significant comorbidities including hypertension, diabetes, and history with previous cancer
- At admission for COVID-19, 40 patients were in complete or partial remission of cancer while 24 were in first or second line therapy, and 13 were relapsed cases of lymphoma
- Common symptoms for these patients upon arrival include dyspnea, cough, fever, and diarrhea
- As of May 26, 2020, 48 patients were discharged, 30 had died, and 11 were still hospitalized
- Most patients required oxygen with a substantial amount, 21, requiring invasive mechanical ventilation
- Survivability of COVID-19 in those who were over the age of 70 was much lower than that of the group under 70
- Patients younger than 70, without relapsed/refractory lymphoma had similar survival rates to that of the general population, while all other groups saw increased rates of mortality
0
1
Updated 2020-11-19
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences